Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64,326,281
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
20,378,033
-
Shares change
-
+817,339
-
Total reported value, excl. options
-
$277,439,038
-
Value change
-
+$6,508,117
-
Number of buys
-
23
-
Number of sells
-
13
-
Price
-
$13.61
Institutional Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q2 2022
As of 30 Jun 2022 Vera Therapeutics, Inc. - COMMON STOCK (VERA) had 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,378,033 shares of stock of the company.
Largest 10 holders included FMR LLC, Sofinnova Investments, Inc., Abingworth LLP, CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Kynam Capital Management, LP, BlackRock Inc., VANGUARD GROUP INC, Vivo Capital, LLC, and Octagon Capital Advisors LP.
This table shows 47 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.